News Quantified

LMAT – lemaitre vascular, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

LeMaitre Vascular, Inc. (NASDAQ: LMAT) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $75.00 price target on the stock, up previously from $59.00.

LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024

LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat? [Yahoo! Finance]

LeMaitre Vascular, Inc. (NASDAQ: LMAT) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.

LeMaitre Vascular, Inc. (NASDAQ: LMAT) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.

14.4%

BEAT

-2.4%

BEAT

3.0%

BEAT

15.2%

BEAT

Stifel Nicolaus

Stifel Nicolaus

Barrington Research

Form ARS LEMAITRE VASCULAR INC For: Dec 31

Form DEF 14A LEMAITRE VASCULAR INC For: Jun 03

Form 4 LEMAITRE VASCULAR INC For: Mar 28 Filed by: SHADAN MARTHA

Form 4 LEMAITRE VASCULAR INC For: Mar 28 Filed by: Roush John A

Form 4 LEMAITRE VASCULAR INC For: Mar 28 Filed by: Ross Bridget A

Top News Gainers

3/23 Form 4 LEMAITRE VASCULAR INC For: Mar 19 Filed by: LeMaitre George W 9.6%

4/6 LeMaitre Vascular Inc (NASDAQ: LMAT) had its price target lowered by analysts at Lake Street Capital from $40.00 to $28.00. They now have a "buy" rating on the stock. 6.1%

4/13 LeMaitre Vascular Withdraws Prior Annual Guidance for 2020 And Announces Preliminary Q1 2020 Financial Results 3.8%

7/20 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 3.6%

10/13 LeMaitre Vascular Acquires Biologic Patch Business from Admedus 3.4%

9/9 Form 4 LEMAITRE VASCULAR INC For: Sep 05 Filed by: LeMaitre George W 3.2%

10/22 Form 4 LEMAITRE VASCULAR INC For: Oct 18 Filed by: Roberts David B 3.1%

7/22 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 3.0%

7/17 Form 4 LEMAITRE VASCULAR INC For: Jul 16 Filed by: O'Connor John James 2.8%

2/11 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $33.00 price target on the stock. 2.8%

Top News Decliners

2/6 Form 8-K LEMAITRE VASCULAR INC For: Feb 06 -19.5%

3/12 Form 10-K LEMAITRE VASCULAR INC For: Dec 31 -18.1%

3/16 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at Sidoti from a "neutral" rating to a "buy" rating. They now have a $38.00 price target on the stock. -9.7%

7/25 LeMaitre Vascular Inc (NASDAQ: LMAT) had its price target raised by analysts at Barrington Research from $32.00 to $37.00. They now have an "outperform" rating on the stock. -8.7%

4/30 Q1/2020 3/31/2020 EPS 0.160 ZacksConsensus 0.160 ActVsEst 0.000 - In-Line -7.4%

4/30 LeMaitre Vascular Inc (NASDAQ: LMAT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -7.2%

4/17 Form 8-K LEMAITRE VASCULAR INC For: Apr 13 -5.6%

4/21 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -5.5%

10/23 Q3/2019 9/30/2019 EPS 0.250 ZacksConsensus 0.210 ActVsEst 0.040 - Beat -4.5%

11/5 Form 4 LEMAITRE VASCULAR INC For: Nov 01 Filed by: LeMaitre George W -4.2%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day